Abstract
Four novel 64Cu complexes ([64Cu(thp)4]+ (1), [64Cu(TPA)4]+ (2), [HC(CO2)(pzMe2)2 64Cu(thp)2] (3) and [HC(CO2)(tz)2 64Cu(thp)2] (4), [where thp is tris(hydroxymethyl)phosphine, TPA is 1,3,5-triaza-7-phosphaadamantane, pzMe2 is 3,5-dimethylpyrazole and tz is 1,2,4-triazole] were successfully synthesized and characterized. The complexes were produced in high radiochemical purity and yield (more than 98%) without the need for further purification. Their logP values and serum stabilities were measured and in vitro behavior was observed in cultured EMT-6 cells. The logP values (± standard deviation) obtained were −2.26 ± 0.04 (1), 0.01 ± 0.01 (2), −1.24 ± 0.03 (3) and −2.06 ± 0.03 (4). Complex 3 demonstrated the highest serum stability, with approximately 33% of the complex still intact after 1-h incubation. Complex 2 showed a rapid cell-association with EMT-6 cells, with more than 8.5% association at 2 h. This association was significantly higher (P < 0.001) than for the other three compounds after a 2-h incubation (1, 1.21%; 3, 0.63%; 4, 2.75%). Biodistribution and small-animal positron emission tomography/computed tomography was undertaken with 1 in mice bearing EMT-6 tumors. EMT-6 tumor uptake was high at 1 h (7.71 ± 2.17 %ID/g) and decreased slowly over 24 h (4 h, 4.90 ± 0.78 %ID/g; 24 h, 3.74 ± 0.73 %ID/g). The PET/CT images show that the EMT-6 tumors can be visualized at all time points. In this proof-of-concept study, we have successfully synthesized and characterized a novel series of versatile water-soluble Cu(I) complexes containing monophosphine ligands. We also report the use of 1 as a building block for new radiopharmaceuticals, perhaps the first time such a method has been used in the production of copper radiopharmaceuticals.
Similar content being viewed by others
References
Blower PJ, Lewis JS, Zweit J (1996) Nucl Med Biol 23:957–980
Welch MJ, Redvanly CS (eds) (2003) Handbook of radiopharmaceuticals. Wiley, Chichester
McQuade P, Rowland DJ, Lewis JS, Welch MJ (2005) Curr Med Chem 12:807–818
Dehdashti F, Grigsby PW, Mintun MA, Lewis JS, Siegel BA, Welch MJ (2003) Int J Radiat Oncol Biol Phys 55:1233–1238
Dehdashti F, Mintun MA, Lewis JS, Bradley J, Govindan R, Laforest R, Welch MJ, Siegel BA (2003) Eur J Nucl Med Mol Imaging 30:844–850
Fujibayashi Y, Taniuchi H, Yonekura Y, Ohtani H, Konishi J, Yokoyama A (1997) J Nucl Med 38:1155–1160
Green MA, Mathias CJ, Welch MJ, McGuire AH, Perry D, Fernandez-Rubio F, Perlmutter JS, Raichle ME, Bergmann SR (1990) J Nucl Med 31:1989–1996
Lewis JS, McCarthy DW, McCarthy TJ, Fujibayashi Y, Welch MJ (1999) J Nucl Med 40:177–183
Taniuchi H, Fujibayashi Y, Yonekura Y, Konishi J, Yokoyama A (1997) J Nucl Med 38:1130–1134
Young H, Carnochan P, Zweit J, Babich J, Cherry S, Ott R (1994) J Nucl Med 21:336–341
Berners-Price SJ, Johnson RK, Mirabelli CK, Faucette LF, McCabe FL, Sadler PJ (1987) Inorg Chem 26:3383–3387
Berners-Price SJ, Sadler PJ (1988) Struct Bonding 70:27–102
Lewis JS, Zweit J, Blower PJ (1998) Polyhedron 17:513–517
Lewis JS, Dearling JLJ, Sosabowski JK, Zweit J, Carnochan P, Kelland LR, Coley HM, Blower PJ (2000) Eur J Nucl Med 27:638–646
Lewis JS, Heath SL, Powell AK, Zweit J, Blower PJ (1997) Dalton Trans 855–861
Lewis JS, Zweit J, Dearling JLJ, Rooney BC, Blower PJ (1996) Chem Commun 1093–1094
Marzano C, Pellei M, Alidori S, Brossa A, Gioia Lobbia G, Tisato F, Santini C (2006) J Inorg Biochem 100:299–304
Marzano C, Pellei M, Colavito D, Alidori S, Gioia Lobbia G, Gandin V, Tisato F, Santini C (2006) J Med Chem 49:7317–7324
Marzano C, Gandin V, Pellei M, Colavito D, Papini G, Gioia Lobbia G, Del Giudice E, Porchia M, Tisato F, Santini C (2007) J Med Chem (in press)
Kirillov AM, Smolenski P, Guedes da Silva MFC, Pombeiro AJL (2007) Eur J Inorg Chem 2686–2692
McCarthy DW, Shefer RE, Klinkowstein RE, Bass LA, Margeneau WH, Cutler CS, Anderson CJ, Welch MJ (1997) Nucl Med Biol 24:35–43
Tai YC, Ruangma A, Rowland DJ, Siegel S, Newport DF, Chow PL, Laforest R (2005) J Nucl Med 46:455–463
Gill JT, Mayerle JJ, Welcker PS, Lewis DF, Ucko DA, Barton DJ, Stowens D, Lippard SJ (1976) Inorg Chem 15:1155–1168
Fife DJ, Moore WM, Morse KW (1984) Inorg Chem 23:1684–1691
Lippard SJ, Mayerle JJ (1972) Inorg Chem 11:753–759
Schmidbaur H, Adlkofer J, Schwirten KT (1972) Chem Ber 105:3382–3388
Carty AJ, Anderson WH, Palenik GJ, Schreiber G (1971) Can J Chem 49:761–766
Cotton FA, Goodgame DML (1960) J Chem Soc 5267–5269
Dines MB (1972) Inorg Chem 11:2949–2952
Katti KV, Gali H, Smith CJ, Berning DE (1999) Acc Chem Res 32:9–17
Saravana Bharathi D, Sridhar MA, Shashidhara Prasad J, Samuelson AG (2001) Inorg Chem Commun 4:490–492
Darensbourg DJ, Decuir TJ, Stafford NW, Robertson JB, Draper JD, Reibenspies JH, Katho A, Joo F (1997) Inorg Chem 36:4218–4226
Mohr F, Cerrada E, Laguna M (2006) Organometallics 25:644–648
Scolaro C, Bergamo A, Brescacin L, Delfino R, Cocchietto M, Laurenczy G, Geldbach TJ, Sava G, Dyson PJ (2005) J Med Chem 48:4161–4171
Phillips AD, Gonsalvi L, Romerosa A, Vizza F, Peruzzini M (2004) Coord Chem Rev 248:955–993
Alberto R (2003) Eur J Nucl Med Mol Imaging 30:1299–1302
Dearling JLJ, Lewis JS, Mullen GED, Welch MJ, Blower PJ (2002) J Biol Inorg Chem 7:249–259
Boswell CA, Sun X, Niu W, Weisman GR, Wong EH, Rheingold AL, Anderson CJ (2004) J Med Chem 47:1465–1474
Spraugue JE, Peng Y, Sun X, Weisman GR, Wong EH, Achilefu S, Anderson CJ (2004) Clin Cancer Res 10:8674–8682
Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, Piwnica-Worms D (1992) J Nucl Med 33:1516–1521
Hill BT (1996) Int J Oncol 9:197–203
Bae KT, Piwnica-Worms D (1997) Q J Nucl Med 41:101–110
Acknowledgements
We wish to acknowledge Raffaella Rossin and Amy L. Vāvere for their help and discussions. We are very grateful for the technical assistance of Dawn Werner, Terry Sharp, Lori Strong, Nicole Fettig, Margaret Morris, Amanda Roth, Ann Stroncek and Jerrel Rutlin for animal handling and microPET imaging support, as well as Susan Adams for cell preparation. Thanks also to Tom Voller and the WUSTL cyclotron facility staff for radionuclide production. This work was partially supported by the National Institutes of Health/National Cancer Institute (NIH/NCI) (R24 CA86307). Small-animal PET imaging is supported by an NIH/NCI SAIRP grant (R24 CA86060) with additional support from the Small Animal Imaging Core (SAIC) of the Alvin J. Siteman Cancer Center at Washington University and Barnes-Jewish Hospital. The SAIC is supported by an NIH/NCI Support Grant P30 CA91842.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Alidori, S., Gioia Lobbia, G., Papini, G. et al. Synthesis, in vitro and in vivo characterization of 64Cu(I) complexes derived from hydrophilic tris(hydroxymethyl)phosphane and 1,3,5-triaza-7-phosphaadamantane ligands. J Biol Inorg Chem 13, 307–315 (2008). https://doi.org/10.1007/s00775-007-0322-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-007-0322-y